FI893795A - Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar. - Google Patents

Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar. Download PDF

Info

Publication number
FI893795A
FI893795A FI893795A FI893795A FI893795A FI 893795 A FI893795 A FI 893795A FI 893795 A FI893795 A FI 893795A FI 893795 A FI893795 A FI 893795A FI 893795 A FI893795 A FI 893795A
Authority
FI
Finland
Prior art keywords
furyltiazolderivat
farmaceutiska
blandingar
nya
foerfarande foer
Prior art date
Application number
FI893795A
Other languages
English (en)
Other versions
FI893795A0 (fi
Inventor
Hisashi Takasugi
Yousuke Katsura
Yoshikazu Inoue
Tetsuo Tomishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819365A external-priority patent/GB8819365D0/en
Priority claimed from GB898905818A external-priority patent/GB8905818D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI893795A0 publication Critical patent/FI893795A0/fi
Publication of FI893795A publication Critical patent/FI893795A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI893795A 1988-08-15 1989-08-11 Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar. FI893795A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819365A GB8819365D0 (en) 1988-08-15 1988-08-15 New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same
GB898905818A GB8905818D0 (en) 1989-03-14 1989-03-14 New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
FI893795A0 FI893795A0 (fi) 1989-08-11
FI893795A true FI893795A (fi) 1990-02-16

Family

ID=26294284

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893795A FI893795A (fi) 1988-08-15 1989-08-11 Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar.

Country Status (12)

Country Link
EP (1) EP0355612B1 (fi)
JP (1) JP2814594B2 (fi)
KR (1) KR900003166A (fi)
CN (1) CN1040796A (fi)
AT (1) ATE109144T1 (fi)
AU (1) AU3934689A (fi)
DE (1) DE68917049T2 (fi)
DK (1) DK391089A (fi)
FI (1) FI893795A (fi)
IL (1) IL91152A0 (fi)
NO (1) NO893256L (fi)
PT (1) PT91415B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
US5512588A (en) * 1991-08-02 1996-04-30 Fujisawa Pharmaceutical Co., Ltd. Furylthiazoles and their use as H2 - receptor antagonists and antimicrobials
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JPWO2016098793A1 (ja) * 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS5936674A (ja) * 1982-08-25 1984-02-28 Yamanouchi Pharmaceut Co Ltd Ｎ−置換グアニジノチアゾ−ル誘導体およびその製造法
JPS59225186A (ja) * 1983-05-18 1984-12-18 Yamanouchi Pharmaceut Co Ltd 新規なグアニジノチアゾ−ル誘導体及びその製造方法
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS62273977A (ja) * 1986-05-21 1987-11-28 Yoshitomi Pharmaceut Ind Ltd フリルチアゾ−ル化合物
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents

Also Published As

Publication number Publication date
JP2814594B2 (ja) 1998-10-22
IL91152A0 (en) 1990-03-19
DK391089D0 (da) 1989-08-09
DK391089A (da) 1990-02-16
JPH0272177A (ja) 1990-03-12
KR900003166A (ko) 1990-03-23
EP0355612A2 (en) 1990-02-28
PT91415B (pt) 1995-05-04
NO893256D0 (no) 1989-08-14
EP0355612A3 (en) 1990-08-22
AU3934689A (en) 1990-02-15
NO893256L (no) 1990-02-16
DE68917049T2 (de) 1995-01-05
CN1040796A (zh) 1990-03-28
PT91415A (pt) 1990-03-08
FI893795A0 (fi) 1989-08-11
ATE109144T1 (de) 1994-08-15
DE68917049D1 (de) 1994-09-01
EP0355612B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
FI862011A0 (fi) Terapeutiska nukleosider.
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ATE49600T1 (de) Kristallinisches kalzium-pseudomonat und verwendung.
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DK122391D0 (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
FR2638161B1 (fr) Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FI893795A0 (fi) Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
DE68927055T2 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
FI881075A (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
FI96855B (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900616D0 (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.
RO94684A2 (ro) Medicament pentru tratamentul unor dermatoze
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
NO890328L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.